Pharma Industry Under Antitrust Scrutiny
Mondaq Business Briefing › Canada Law Articles in English (2009)
Linked as:
Extract
Pharma Industry Under Antitrust Scrutiny
Competition authorities continue to examine various aspects of the pharmaceutical industry. Most recently, the European Commission conducted surprise inspections of certain pharmaceutical companies, seeking evidence of anti-competitive conduct. One issue of concern is the impact on competition of "pay-for-delay" or "reverse payment" patent settlement agreements, whereby branded pharmaceutical manufacturers make payments to generic manufac...
See the full content of this document
Sponsored links
